Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.


GREY:ATBPF - Post by User

Comment by MrMugsyon Jul 27, 2021 1:52pm
147 Views
Post# 33610989

RE:RE:RE:And how did everyone like that little update?

RE:RE:RE:And how did everyone like that little update?
Yellowknifer69 wrote: Well to be honest, nothing unexpected but it was better reading the corporate update than it is to read the drivel posted by folks like 123 and YukonJezza - those guys need to get a life.

Yellowknifer


What I like ...
1.  maximizing P3 success - glad he said it but I knew it was going to be maximized with Stauffer, the IDMC team and the training/data collection for participants.
2.  US exchange in sync with P3 - expected but nice to hear.  That means we're likely going late 2021 or really early 2022.  To be determined but I think 2021 still has a possibility but depends on things we just don't know about (pending news).
3.  Sounds like Dan is hinting that Citagenix will be gone before going to a US exchange - that would clean things up before the US Exchange and before P3 begin - that's my opinion.
4.  Multiple global partners in negotiations ... can only be helpful to ATE to have multiple interests out there and our ability to choose.
5.  Fresh IP for 352 and 340 - used to only be 340 but ATE made an important change here.  When we further extend IP to existing product, we're only talking about OTENA.  This will most certainly become a talking point in negotiations regarding future IP.  If a partner doesn't want new IP drug as well then they're only bidding on OTENA.  That would leave the new IP as a future contender to OTENA and who wants that ?  They're going to need to bid on the future molecule as well or be left competing with it one day.
6.  As much as it's about OTENA and extending specific drug patents - in negotiations a keen partner will be interested in hearing about our ability to extend old drug patents and make them new again.  That's the real value here (IMO).  With multiple potential partners out there, someone is going to be more aligned with us and our abilities.  Someone is going to see that value and wonder if they should make a move (IMO).

That's why I'm all bulked up baby - so I don't have to worry about timing.

On my lounger ... enjoying the sun ... waiting for someone to bring me a Margarita !

<< Previous
Bullboard Posts
Next >>